| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 1.997.798.996 $ | +713.310.050 $ | +56,1 % | 43 | 1.320.591.769 $ | -144.873.869 $ | +3,9 % | 40 | 1.609.916.188 $ | +415.514.849 $ | +66,8 % | 38 | |||
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 482.682.924 $ | +232.037.290 $ | +92,6 % | 1 | 250.645.634 $ | +45.361.061 $ | +22,1 % | 1 | 205.284.573 $ | +81.654.122 $ | +66,0 % | 1 |
| GeneDx Holdings Corp. | WGS | → 0 | Neutral | 254.496.809 $ | +61.376.737 $ | +31,8 % | 1 | 193.120.072 $ | -197.991.678 $ | -50,6 % | 1 | 391.111.750 $ | +67.119.901 $ | +20,7 % | 1 |
| Relay Therapeutics, Inc. | RLAY | → 0 | Neutral | 300.019.340 $ | +156.554.529 $ | +109,1 % | 1 | 143.464.811 $ | +33.454.575 $ | +30,4 % | 1 | 110.010.236 $ | +50.808.227 $ | +85,8 % | 1 |
| BIOLIFE SOLUTIONS INC | BLFS | → 0 | 131.457.200 $ | +17.794.492 $ | +15,7 % | 1 | 113.662.708 $ | -30.381.542 $ | -21,1 % | 1 | 144.044.250 $ | -27.055.529 $ | -15,8 % | 1 | |
| STANDARD BIOTOOLS INC. | LAB | → 0 | Neutral | 73.042.478 $ | -8.576.521 $ | -10,5 % | 1 | 81.618.999 $ | -32.024.337 $ | -28,2 % | 1 | 113.643.336 $ | +12.816.823 $ | +12,7 % | 1 |
| ILLUMINA, INC. | ILMN | → 0 | Neutral | 93.189.900 $ | +27.862.100 $ | +42,6 % | 1 | 65.327.800 $ | -13.368.200 $ | -17,0 % | 1 | 78.696.000 $ | +28.836.750 $ | +57,8 % | 1 |
| Structure Therapeutics Inc. | GPCR | → 0 | Schwach | 63.062.250 $ | +6.427.250 $ | +11,3 % | 1 | 56.635.000 $ | -25.086.250 $ | -30,7 % | 1 | 81.721.250 $ | +38.181.250 $ | +87,7 % | 1 |
| Avidity Biosciences, Inc. | RNA | → 0 | 72.130.000 $ | -5.424.600 $ | -7,0 % | 1 | |||||||||
| Denali Therapeutics Inc. | DNLI | → 0 | Neutral | 52.597.400 $ | +17.269.400 $ | +48,9 % | 1 | 35.328.000 $ | +4.949.600 $ | +16,3 % | 1 | 30.378.400 $ | +17.455.600 $ | +135,1 % | 1 |
| Neurogene Inc. | NGNE | → 0 | Neutral | 48.601.603 $ | +19.967.125 $ | +69,7 % | 1 | 28.634.478 $ | +1.950.041 $ | +7,3 % | 1 | 26.684.437 $ | +4.235.831 $ | +18,9 % | 1 |
| 10x Genomics, Inc. | TXG | → 0 | Neutral | 40.257.000 $ | -8.041.250 $ | -16,6 % | 1 | 48.298.250 $ | +25.464.250 $ | +111,5 % | 1 | 22.834.000 $ | +22.834.000 $ | 1 | |
| Beam Therapeutics Inc. | BEAM | → 0 | Neutral | 46.332.000 $ | +14.161.500 $ | +44,0 % | 1 | 32.170.500 $ | -12.181.500 $ | -27,5 % | 1 | 44.352.000 $ | +5.520.000 $ | +14,2 % | 1 |
| Guardant Health, Inc. | GH | → 0 | Neutral | 27.755.550 $ | -1.341.000 $ | -4,6 % | 1 | 29.096.550 $ | -9.716.650 $ | -25,0 % | 1 | 38.813.200 $ | +32.565.200 $ | +521,2 % | 1 |
| Scholar Rock Holding Corp | SRRK | → 0 | Neutral | 36.575.000 $ | +19.369.000 $ | +112,6 % | 1 | 17.206.000 $ | +5.753.000 $ | +50,2 % | 1 | 11.453.000 $ | +11.453.000 $ | 1 | |
| Personalis, Inc. | PSNL | → 0 | Neutral | 34.170.000 $ | +23.978.000 $ | +235,3 % | 1 | 10.192.000 $ | +10.192.000 $ | 1 | |||||
| GRAIL, Inc. | GRAL | → 0 | Neutral | 32.769.600 $ | +20.883.200 $ | +175,7 % | 1 | 11.886.400 $ | +11.886.400 $ | 1 | |||||
| Maze Therapeutics, Inc. | MAZE | → 0 | Neutral | 25.180.693 $ | +2.528.812 $ | +11,2 % | 1 | 22.651.881 $ | -8.787.565 $ | -28,0 % | 1 | 31.439.446 $ | +11.762.284 $ | +59,8 % | 1 |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | → 0 | Neutral | 22.577.250 $ | -2.238.000 $ | -9,0 % | 1 | 24.815.250 $ | -5.008.500 $ | -16,8 % | 1 | 29.823.750 $ | +4.743.750 $ | +18,9 % | 1 |
| Hims & Hers Health, Inc. | HIMS | → 0 | Neutral | 24.269.000 $ | +9.737.000 $ | +67,0 % | 1 | 14.532.000 $ | +2.031.050 $ | +16,2 % | 1 | 12.500.950 $ | -544.650 $ | -4,2 % | 1 |
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Neutral | 22.132.500 $ | +7.605.000 $ | +52,3 % | 1 | 14.527.500 $ | +6.277.500 $ | +76,1 % | 1 | 8.250.000 $ | +8.250.000 $ | 1 | |
| AgomAb Therapeutics NV | AGMB | → 0 | Neutral | 20.119.000 $ | +3.859.500 $ | +23,7 % | 1 | 16.259.500 $ | +16.259.500 $ | 1 | |||||
| ARS Pharmaceuticals, Inc. | SPRY | → 0 | Schwach | 18.640.000 $ | +2.560.000 $ | +15,9 % | 1 | ||||||||
| Septerna, Inc. | SEPN | → 0 | Neutral | 18.528.945 $ | +5.233.915 $ | +39,4 % | 1 | 13.295.030 $ | -2.130.082 $ | -13,8 % | 1 | 15.425.112 $ | +5.018.141 $ | +48,2 % | 1 |
| Parabilis Medicines, Inc. | PBLS | → 0 | Neutral | 17.672.535 $ | +17.672.535 $ | 1 | |||||||||
| Sionna Therapeutics, Inc. | SION | → 0 | Schwach | 17.596.000 $ | +17.596.000 $ | 1 | |||||||||
| Tempus AI, Inc. | TEM | → 0 | Schwach | 13.300.423 $ | -4.067.776 $ | -23,4 % | 1 | 17.368.199 $ | -6.370.791 $ | -26,8 % | 1 | ||||
| UNITEDHEALTH GROUP INC | UNH | → 0 | Sehr stark | 16.505.500 $ | +7.873.000 $ | +91,2 % | 1 | ||||||||
| VERACYTE, INC. | VCYT | → 0 | Neutral | 16.227.569 $ | +7.327.688 $ | +82,3 % | 1 | 8.899.881 $ | -2.732.686 $ | -23,5 % | 1 | 11.632.567 $ | +2.146.913 $ | +22,6 % | 1 |
| QIAGEN N.V. | QGEN | → 0 | Sehr stark | 14.414.400 $ | +14.414.400 $ | 1 | |||||||||
| Adlai Nortye Group Ltd. | ANL | → 0 | Neutral | 14.375.000 $ | +10.648.850 $ | +285,8 % | 1 | 3.726.150 $ | +3.726.150 $ | 1 | |||||
| Prime Medicine, Inc. | PRME | → 0 | Neutral | 11.686.876 $ | +665.107 $ | +6,0 % | 1 | 11.021.769 $ | +31.672 $ | +0,3 % | 1 | 10.990.097 $ | -6.556.053 $ | -37,4 % | 1 |
| DEXCOM INC | DXCM | → 0 | Neutral | 11.614.750 $ | +11.614.750 $ | 1 | |||||||||
| Absci Corp | ABSI | → 0 | Neutral | 11.280.083 $ | +8.360.303 $ | +286,3 % | 1 | 2.919.780 $ | -476.897 $ | -14,0 % | 1 | 3.396.677 $ | +437.967 $ | +14,8 % | 1 |
| Cigna Group | CI | → 0 | Sehr stark | 11.009.200 $ | +11.009.200 $ | 1 | |||||||||
| QUEST DIAGNOSTICS INC | DGX | → 0 | Stark | 10.597.500 $ | +798.500 $ | +8,1 % | 1 | 9.799.000 $ | +1.122.500 $ | +12,9 % | 1 | 8.676.500 $ | +8.676.500 $ | 1 | |
| INCYTE CORP | INCY | → 0 | Neutral | 9.877.000 $ | +1.396.000 $ | +16,5 % | 1 | ||||||||
| Sarepta Therapeutics, Inc. | SRPT | → 0 | Neutral | 8.445.900 $ | +8.445.900 $ | 1 | |||||||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Neutral | 8.388.000 $ | +8.388.000 $ | 1 | |||||||||
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | PACB | → 0 | Schwach | 1.215.929 $ | +260.557 $ | +27,3 % | 1 | 955.372 $ | -6.943.072 $ | -87,9 % | 1 | 7.898.444 $ | +6.972.022 $ | +752,6 % | 1 |
| uniQure N.V. | QURE | → 0 | Neutral | 6.909.000 $ | +6.909.000 $ | 1 | |||||||||
| Intellia Therapeutics, Inc. | NTLA | → 0 | Schwach | 6.006.600 $ | +1.455.500 $ | +32,0 % | 1 | 4.551.100 $ | +4.551.100 $ | 1 | |||||
| Moderna, Inc. | MRNA | → 0 | Schwach | 5.252.250 $ | +1.442.250 $ | +37,9 % | 1 | 3.810.000 $ | +3.810.000 $ | 1 | |||||
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 4.754.100 $ | +598.000 $ | +14,4 % | 1 | 4.156.100 $ | +4.156.100 $ | 1 | |||||
| Legend Biotech Corp | LEGN | → 0 | Neutral | 4.674.100 $ | +4.674.100 $ | 1 | |||||||||
| Monte Rosa Therapeutics, Inc. | GLUE | → 0 | Schwach | 4.501.539 $ | +1.441.609 $ | +47,1 % | 1 | 3.059.930 $ | +1.711.230 $ | +126,9 % | 1 | 1.348.700 $ | +711.336 $ | +111,6 % | 1 |
| BridgeBio Oncology Therapeutics, Inc. | BBOT | → 0 | Schwach | 2.151.217 $ | -375.475 $ | -14,9 % | 1 | 2.526.692 $ | -1.007.854 $ | -28,5 % | 1 | 3.534.546 $ | +265.373 $ | +8,1 % | 1 |
| Century Therapeutics, Inc. | IPSC | → 0 | Neutral | 3.009.066 $ | +233.357 $ | +8,4 % | 1 | 2.775.709 $ | +1.553.906 $ | +127,2 % | 1 | 1.221.803 $ | +610.164 $ | +99,8 % | 1 |
| Contineum Therapeutics, Inc. | CTNM | → 0 | Neutral | 2.431.178 $ | +493.949 $ | +25,5 % | 1 | 1.937.229 $ | +241.783 $ | +14,3 % | 1 | 1.695.446 $ | -47.467 $ | -2,7 % | 1 |
| Editas Medicine, Inc. | EDIT | → 0 | Neutral | 1.441.800 $ | +1.441.800 $ | 1 | |||||||||
| Kardigan, Inc. | KARD | → 0 | Neutral | 1.192.500 $ | +1.192.500 $ | 1 | |||||||||
| RECURSION PHARMACEUTICALS, INC. | RXRX | → 0 | Schwach | 606.735 $ | +99.193 $ | +19,5 % | 1 | 507.542 $ | -168.629 $ | -24,9 % | 1 | 676.171 $ | -130.605 $ | -16,2 % | 1 |
| Ginkgo Bioworks Holdings, Inc. | DNA | → 0 | Schwach | 361.646 $ | +137.944 $ | +61,7 % | 1 | 223.702 $ | -79.555 $ | -26,2 % | 1 | 303.257 $ | -228.811 $ | -43,0 % | 1 |
| Tenaya Therapeutics, Inc. | TNYA | → 0 | Schwach | 267.531 $ | +16.904 $ | +6,7 % | 1 | 250.627 $ | -6.914 $ | -2,7 % | 1 | 257.541 $ | -328.849 $ | -56,1 % | 1 |
| Gesamt | 1.997.798.996 $ | +713.310.050 $ | +56,1 % | 43 | 1.320.591.769 $ | -144.873.869 $ | +3,9 % | 40 | 1.609.916.188 $ | +415.514.849 $ | +66,8 % | 38 | |||